Pharma channel feed – Endpoints News

Pharma channel feed

Servier, Pfizer get FDA OK to start US testing of an off-the-shelf CAR-T from Cellectis

9 years ago

Retrophin takes the ax to its Cambridge office as it concentrates on late-stage R&D push

9 years ago

Merck KGaA in talks to sell its biosimilars R&D ops as shakeout looms

9 years ago

Cummings: Trump offers a high-five on Medicare drug price negotiations, a federal formulary and imports

9 years ago

Do big R&D budgets justify US premium drug prices? No way, analysts scoff

9 years ago

Trump tweets a new vow to spur competition in the pharma biz, slashing prices

9 years ago

Merck, Pfizer line up a big FDA decision on a blockbuster hopeful, staring down some major league competition

9 years ago

With a big cash assist from local officials, BeiGene is building a $330M biologics facility in China

9 years ago

FDA lifts its hold on vadastuximab talirine after Seattle Genetics adds new safeguards

9 years ago

Snubbed at the FDA, PTC files their three-time loser for Duchenne MD over protest

9 years ago

Regeneron, Sanofi, get ready to duke it out with Pfizer over a megablockbuster eczema market

9 years ago

Allergan scores an FDA OK for a new drug targeting night-time urination

9 years ago

More Senators accuse Marathon CEO Aronin of exploiting Duchenne MD patients as well as FDA’s orphan incentives

9 years ago

J&J may be late to the psoriasis drug market party, but it’s planning to make a splash with guselkumab

9 years ago

Sanofi steps up with a $645M deal to partner with AstraZeneca on a late-stage RSV antibody

9 years ago

IV formulation of Scynexis' lead antifungal gets sidelined by the FDA as regulators probe blood clots

9 years ago

Aurinia bounces back, shares soar on positive data for lupus drug

9 years ago

Celgene, Agios beat a short path to an FDA decision on AML drug

9 years ago

The top 10 orphan drugs in the late-stage pipeline

9 years ago

Trump attacks “slow and burdensome” drug approval process, triggering a pitch from Amicus CEO

9 years ago

Lexicon bags FDA OK on lead drug for carcinoid syndrome, preps for a commercial launch

9 years ago

Cempra slashes staff while shares tank (again) after a new series of setbacks for lead antibiotic

9 years ago

Gates-backed Affinivax grabs $10M upfront and a major league partner for a groundbreaking attempt to beat Pfizer’s superstar vaccine

9 years ago

Gerngross’ Adimab hands over RSV antibodies to Arsanis, a biotech he co-founded in Vienna

9 years ago

First page Previous page 331 332 333334335 336 337 Next page Last page